Severity 3 of 5
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Severity 3 (High) recalls have a known hazard but no confirmed illness, injury, or property damage in the source text. The risk is theoretical-but-real: a pathogen pre-emptively pulled from shelves before anyone got sick, an allergen mislabeling on an uncommon allergen, a precautionary correction on a device that hasn't yet malfunctioned in the field. Most allergen recalls land here, as do most preventive food recalls based on routine sampling. You should still stop using the product, but you don't need to panic.
The full rubric is on the methodology page. Severity is computed deterministically from the agency’s own classification plus the source text — no editorial vibes.
Pending LLM rewrite. Source: CPSC 26414.
Pending LLM rewrite. Source: CPSC 26427.
Pending LLM rewrite. Source: CPSC 26411.
Pending LLM rewrite. Source: CPSC 26425.
Pending LLM rewrite. Source: CPSC 26422.
Pending LLM rewrite. Source: CPSC 26424.
Pending LLM rewrite. Source: CPSC 26428.
Pending LLM rewrite. Source: CPSC 26409.
Pending LLM rewrite. Source: CPSC 26417.
Pending LLM rewrite. Source: FDA_DEVICE Z-1795-2026.
Zarlengo Italian Ice is recalling Chocolate Chocolate Chip Gelato in multiple sizes because soy lecithin is listed in the ingredients but soy is not declared in the allergen statement, posing a risk to consumers with soy allergies.
Pending LLM rewrite. Source: FDA_DRUG D-0439-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1712-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1722-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0662-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1720-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1715-2026.
Blueroot Health, Inc. is recalling Vital Nutrients Aller-C vitamin supplements because they contain undeclared egg, soy, and hazelnut allergens, posing a risk to consumers with allergies to these ingredients.
Pending LLM rewrite. Source: FDA_DEVICE Z-1727-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1725-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1778-2026.
Pending LLM rewrite. Source: FDA_FOOD H-0657-2026.
Pending LLM rewrite. Source: FDA_DEVICE Z-1721-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0434-2026.
Pending LLM rewrite. Source: FDA_DRUG D-0435-2026.